Cargando…
Sub-anesthesia Dose of Isoflurane in 60% Oxygen Reduces Inflammatory Responses in Experimental Sepsis Models
BACKGROUND: Sepsis is a major cause of mortality in Intensive Care Units. Anesthetic dose isoflurane and 100% oxygen were proved to be beneficial in sepsis; however, their application in septic patients is limited because long-term hyperoxia may induce oxygen toxicity and anesthetic dose isoflurane...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381319/ https://www.ncbi.nlm.nih.gov/pubmed/28345549 http://dx.doi.org/10.4103/0366-6999.202734 |
_version_ | 1782519916311609344 |
---|---|
author | Huang, Yi Wang, Xiao-Xia Sun, Dong-Dong Zhang, Ze-Xin Yang, Wan-Wan Shao, Tian Han, Han Zhang, Er-Fei Pu, Zhong-Shu Hou, Zuo-Xu Dong, Hai-Long Xiong, Li-Ze Hou, Li-Chao |
author_facet | Huang, Yi Wang, Xiao-Xia Sun, Dong-Dong Zhang, Ze-Xin Yang, Wan-Wan Shao, Tian Han, Han Zhang, Er-Fei Pu, Zhong-Shu Hou, Zuo-Xu Dong, Hai-Long Xiong, Li-Ze Hou, Li-Chao |
author_sort | Huang, Yi |
collection | PubMed |
description | BACKGROUND: Sepsis is a major cause of mortality in Intensive Care Units. Anesthetic dose isoflurane and 100% oxygen were proved to be beneficial in sepsis; however, their application in septic patients is limited because long-term hyperoxia may induce oxygen toxicity and anesthetic dose isoflurane has potential adverse consequences. This study was scheduled to find the optimal combination of isoflurane and oxygen in protecting experimental sepsis and its mechanisms. METHODS: The effects of combined therapy with isoflurane and oxygen on lung injury and sepsis were determined in animal models of sepsis induced by cecal ligation and puncture (CLP) or intraperitoneal injection of lipopolysaccharide (LPS) or zymosan. Mouse RAW264.7 cells or human peripheral blood mononuclear cells (PBMCs) were treated by LPS to probe mechanisms. The nuclear factor kappa B (NF-κB) signaling molecules were examined by Western blot and cellular immunohistochemistry. RESULTS: The 0.5 minimum alveolar concentration (MAC) isoflurane in 60% oxygen was the best combination of oxygen and isoflurane for reducing mortality in experimental sepsis induced by CLP, intraperitoneal injection of LPS, or zymosan. The 0.5 MAC isoflurane in 60% oxygen inhibited proinflammatory cytokines in peritoneal lavage fluids (tumor necrosis factor-alpha [TNF-α]: 149.3 vs. 229.7 pg/ml, interleukin [IL]-1β: 12.5 vs. 20.6 pg/ml, IL-6: 86.1 vs. 116.1 pg/ml, and high-mobility group protein 1 [HMGB1]: 323.7 vs. 449.3 ng/ml; all P < 0.05) and serum (TNF-α: 302.7 vs. 450.7 pg/ml, IL-1β: 51.7 vs. 96.7 pg/ml, IL-6: 390.4 vs. 722.5 pg/ml, and HMGB1: 592.2 vs. 985.4 ng/ml; all P < 0.05) in septic animals. In vitro experiments showed that the 0.5 MAC isoflurane in 60% oxygen reduced inflammatory responses in mouse RAW264.7 cells, after LPS stimulation (all P < 0.05). Suppressed activation of NF-κB pathway was also observed in mouse RAW264.7 macrophages and human PBMCs after LPS stimulation or plasma from septic patients. The 0.5 MAC isoflurane in 60% oxygen also prevented the increases of phospho-IKKβ/β, phospho-IκBβ, and phospho-p65 expressions in RAW264.7 macrophages after LPS stimulation (all P < 0.05). CONCLUSION: Combined administration of a sedative dose of isoflurane with 60% oxygen improves survival of septic animals through reducing inflammatory responses. |
format | Online Article Text |
id | pubmed-5381319 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-53813192017-04-26 Sub-anesthesia Dose of Isoflurane in 60% Oxygen Reduces Inflammatory Responses in Experimental Sepsis Models Huang, Yi Wang, Xiao-Xia Sun, Dong-Dong Zhang, Ze-Xin Yang, Wan-Wan Shao, Tian Han, Han Zhang, Er-Fei Pu, Zhong-Shu Hou, Zuo-Xu Dong, Hai-Long Xiong, Li-Ze Hou, Li-Chao Chin Med J (Engl) Original Article BACKGROUND: Sepsis is a major cause of mortality in Intensive Care Units. Anesthetic dose isoflurane and 100% oxygen were proved to be beneficial in sepsis; however, their application in septic patients is limited because long-term hyperoxia may induce oxygen toxicity and anesthetic dose isoflurane has potential adverse consequences. This study was scheduled to find the optimal combination of isoflurane and oxygen in protecting experimental sepsis and its mechanisms. METHODS: The effects of combined therapy with isoflurane and oxygen on lung injury and sepsis were determined in animal models of sepsis induced by cecal ligation and puncture (CLP) or intraperitoneal injection of lipopolysaccharide (LPS) or zymosan. Mouse RAW264.7 cells or human peripheral blood mononuclear cells (PBMCs) were treated by LPS to probe mechanisms. The nuclear factor kappa B (NF-κB) signaling molecules were examined by Western blot and cellular immunohistochemistry. RESULTS: The 0.5 minimum alveolar concentration (MAC) isoflurane in 60% oxygen was the best combination of oxygen and isoflurane for reducing mortality in experimental sepsis induced by CLP, intraperitoneal injection of LPS, or zymosan. The 0.5 MAC isoflurane in 60% oxygen inhibited proinflammatory cytokines in peritoneal lavage fluids (tumor necrosis factor-alpha [TNF-α]: 149.3 vs. 229.7 pg/ml, interleukin [IL]-1β: 12.5 vs. 20.6 pg/ml, IL-6: 86.1 vs. 116.1 pg/ml, and high-mobility group protein 1 [HMGB1]: 323.7 vs. 449.3 ng/ml; all P < 0.05) and serum (TNF-α: 302.7 vs. 450.7 pg/ml, IL-1β: 51.7 vs. 96.7 pg/ml, IL-6: 390.4 vs. 722.5 pg/ml, and HMGB1: 592.2 vs. 985.4 ng/ml; all P < 0.05) in septic animals. In vitro experiments showed that the 0.5 MAC isoflurane in 60% oxygen reduced inflammatory responses in mouse RAW264.7 cells, after LPS stimulation (all P < 0.05). Suppressed activation of NF-κB pathway was also observed in mouse RAW264.7 macrophages and human PBMCs after LPS stimulation or plasma from septic patients. The 0.5 MAC isoflurane in 60% oxygen also prevented the increases of phospho-IKKβ/β, phospho-IκBβ, and phospho-p65 expressions in RAW264.7 macrophages after LPS stimulation (all P < 0.05). CONCLUSION: Combined administration of a sedative dose of isoflurane with 60% oxygen improves survival of septic animals through reducing inflammatory responses. Medknow Publications & Media Pvt Ltd 2017-04-05 /pmc/articles/PMC5381319/ /pubmed/28345549 http://dx.doi.org/10.4103/0366-6999.202734 Text en Copyright: © 2017 Chinese Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Huang, Yi Wang, Xiao-Xia Sun, Dong-Dong Zhang, Ze-Xin Yang, Wan-Wan Shao, Tian Han, Han Zhang, Er-Fei Pu, Zhong-Shu Hou, Zuo-Xu Dong, Hai-Long Xiong, Li-Ze Hou, Li-Chao Sub-anesthesia Dose of Isoflurane in 60% Oxygen Reduces Inflammatory Responses in Experimental Sepsis Models |
title | Sub-anesthesia Dose of Isoflurane in 60% Oxygen Reduces Inflammatory Responses in Experimental Sepsis Models |
title_full | Sub-anesthesia Dose of Isoflurane in 60% Oxygen Reduces Inflammatory Responses in Experimental Sepsis Models |
title_fullStr | Sub-anesthesia Dose of Isoflurane in 60% Oxygen Reduces Inflammatory Responses in Experimental Sepsis Models |
title_full_unstemmed | Sub-anesthesia Dose of Isoflurane in 60% Oxygen Reduces Inflammatory Responses in Experimental Sepsis Models |
title_short | Sub-anesthesia Dose of Isoflurane in 60% Oxygen Reduces Inflammatory Responses in Experimental Sepsis Models |
title_sort | sub-anesthesia dose of isoflurane in 60% oxygen reduces inflammatory responses in experimental sepsis models |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381319/ https://www.ncbi.nlm.nih.gov/pubmed/28345549 http://dx.doi.org/10.4103/0366-6999.202734 |
work_keys_str_mv | AT huangyi subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels AT wangxiaoxia subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels AT sundongdong subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels AT zhangzexin subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels AT yangwanwan subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels AT shaotian subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels AT hanhan subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels AT zhangerfei subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels AT puzhongshu subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels AT houzuoxu subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels AT donghailong subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels AT xionglize subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels AT houlichao subanesthesiadoseofisofluranein60oxygenreducesinflammatoryresponsesinexperimentalsepsismodels |